Erythropoietin should be part of congestive heart failure management-Reference-Cited by-同舟云学术

Erythropoietin should be part of congestive heart failure management

Published:2003-11 Issue: Volume:64 Page:S40-S47
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Silverberg Donald S.,Wexler Dov,Blum Miriam,Schwartz Doran,Wollman Yoram,Iaina Adrian

Publisher

Elsevier BV

Subject

Nephrology

Reference73 articles.

1. Long term trends in the incidence of and survival with heart failure;Levy;New Engl J Med,2002

2. Management of heart failure in primary care (The IMPROVEMENT of heart failure programme): An international survey;Cleland;Lancet,2002

3. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and renal failure and markedly reduces hospitalization;Silverberg;Clin Nephrol,2002

4. The effect of correction of anemia in diabetic and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutanous erythropoietin and intravenous iron;Silverberg;Nephrol Dial Transplant,2003

5. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations;Silverberg;J Am Coll Cardiol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical comorbidity is associated with overnight hospitalization in U.S. adults with asthma: an assessment of the 2005–2018 National Health and Nutrition Examination Surveys;Journal of Asthma;2024-08-27

2. Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults;Cureus;2024-05-16

3. The Characteristics of Dialysis Membranes: Benefits of the AN69 Membrane in Hemodialysis Patients;Journal of Clinical Medicine;2023-01-31

4. Esterification promotes the intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend its effective duration;Biochemical Pharmacology;2022-03

5. The effect of myxomatous mitral valve disease severity on packed cell volume in dogs;Journal of Small Animal Practice;2021-02-18